Keros Therapeutics Inc KROS Balance Sheet

Income Statement

Quarter End	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024
	USD ($)	USD ($)	USD ($)	USD ($)	USD ($)	USD ($)
Total Assets	306.78M	384.44M	356.31M	326.25M	370.03M	485.82M	455.02M	579.27M
Total Current Assets	285.77M	362.22M	334.31M	304.44M	347.29M	463.13M	432.71M	552.05M
Cash and Equivalents	279.05M	351.43M	322.03M	287.89M	331.15M	442.44M	405.86M	530.68M
Total Non-Current Assets	23.04M	22.21M	22M	21.81M	26.87M	22.69M	22.31M	27.23M
Total Liabilities	29.36M	29.45M	30.05M	30.41M	37.81M	31.87M	34.11M	46.44M
Total Current Liabilities	16.55M	15.46M	16.1M	16.7M	24.37M	18.72M	21.25M	29.01M
Total Non-Current Liabilities	12.81M	13.99M	13.95M	13.7M	13.44M	13.15M	12.86M	17.43M
Common Equity	2k	3k	3k	3k	3k	3k	3k	4k
Retained Earnings	-228.43M	-264.24M	-301.74M	-341.18M	-381.43M	-424.54M	-469.8M	-522.75M

Year End December 30 2023	2018	2019	2020	2021	2022	2023
	USD ($)	USD ($)	USD ($)	USD ($)	USD ($)	USD ($)
Total Assets	27.41M	10.96M	269.44M	255.25M	306.78M	370.03M
Total Current Assets	25.53M	8.93M	267.73M	251.44M	285.77M	347.29M
Cash and Equivalents	23.26M	7.02M	265.88M	230.04M	279.05M	331.15M
Total Non-Current Assets	-7.18M	-19.45M	261.72M	243.17M	277.42M	332.21M
Total Liabilities	14.65M	10.46M	7.72M	12.08M	29.36M	37.81M
Total Current Liabilities	11.47M	4.49M	7.18M	11.85M	16.55M	24.37M
Total Non-Current Liabilities	3.19M	5.97M	538k	231k	12.81M	13.44M
Total Equity	-7.18M	-19.45M	261.72M	243.17M	277.42M	332.21M
Common Equity	1,000	1,000	2k	2k	2k	3k
Retained Earnings	-7.31M	-19.65M	-65.01M	-123.76M	-228.43M	-381.43M